Patients with diabetes ages 55 and up treated with aliskiren-hydrochlorothiazide had better systolic blood pressure rates than those who had hydrochlorothiazide treatment alone, according to a study by the Medical University of South Carolina in Charleston. Experts found that 47.1% of patients with metabolic syndrome or diabetes who went on aliskiren-HCTZ medication attained ideal BP levels compared with 34.6% of those in HCTZ therapy alone.

Related Summaries